Search Within

Marissa Balak

Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. GSK Faculty (9)
  2. Department of Pathology and Laboratory Medicine (8)
  3. Department of Medicine (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Solid Tumor Oncology Division (7)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. William Pao (10)
  2. Gregory Riely (6)
  3. Marc Ladanyi (6)
  4. Vincent Miller (6)
  5. Yixuan Gong (5)
  6. Maureen Zakowski (4)

More People

Years
  1. 2009 (1)
  2. 2008 (2)
  3. 2007 (5)
  4. 2006 (3)
Publications
  1. Clinical Cancer Research (3)
  2. Journal of Clinical Oncology (2)
  3. Molecular Cancer Therapeutics (2)
  4. PLoS ONE (2)
  5. Cancer Research (1)
  6. PLos Medicine (1)
Publishers
  1. American Association for Cancer Research (6)
  2. Public Library of Science (3)
  3. American Society of Clinical Oncology (2)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhanced motor function by training in spinal cord contused rats following radiation therapy
    Journal Article

    Ichiyama, R.; Potuzak, M.; Balak, M.; Kalderon, N.; Edgerton, V. R.
    PLoS ONE (2009)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma
    Journal Article

    Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Identifying strategies to enhance responses induced by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas
    Meeting Abstract

    Gong, Y.; Somwar, R.; Politi, K.; Balak, M.; Chmielecki, J.; Jiang, X.; Pao, W.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors
    Journal Article

    Regales, L.; Balak, M. N.; Gong, Y.; Politi, K.; Sawai, A.; Le, C.; Koutcher, J. A.; Solit, D. B.; Rosen, N.; Zakowski, M. F.; more...
    PLoS ONE (2007)

    Fulltext@MSK | Save
  • The epidermal growth factor receptor D761Y mutation and effect of tyrosine kinase inhibitor - Response
    Journal Article

    Pao, W.; Gong, Y.; Balak, M.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas
    Journal Article

    Gong, Y.; Somwar, R.; Politi, K.; Balak, M.; Chmielecki, J.; Jiang, X.; Pao, W.
    PLos Medicine (2007)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save